Dr Reddy’s Laboratories launches generic version of fesoterodine fumarate tablets in US
PTI, Jul 8, 2022, 8:15 PM IST
New Delhi: Dr Reddy’s Laboratories Ltd on Friday said it has launched its generic version of fesoterodine fumarate extended-release tablets used for treating overactive bladder in the US market.
The launch follows the approval granted by the US Food and Drug Administration (USFDA), the pharma company said in a regulatory filing.
The company’s fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added.
Citing IQVIA data, Dr Reddy’s said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
People single all their lives might have low life satisfaction: Study
Drinking tea, coffee linked to lower risk of head and neck cancer: Study
Study shows how brain chemicals control eating, could help develop improved obesity drugs
‘Faster walkers’ had significantly lower risk of diabetes, hypertension: Study
World Meditation Day 2024: Celebrating inner peace and well-being
MUST WATCH
Latest Additions
Udupi: Bruhat Geetotsava concludes at Sri Krishna Matha
Space for Manmohan Singh’s memorial, Congress playing ‘cheap politics’: Nadda
Middleman held in connection with bribery case involving ED official: CBI
2 detained under PSA, PIT-NDPS Act in J&K’s Samba, Jammu
PM Modi calls Gukesh an embodiment of calmness and humility
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.